» Articles » PMID: 33101294

Innate Immune Responses to Acute Viral Infection During Pregnancy

Overview
Journal Front Immunol
Date 2020 Oct 26
PMID 33101294
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Immunological adaptations in pregnancy allow maternal tolerance of the semi-allogeneic fetus but also increase maternal susceptibility to infection. At implantation, the endometrial stroma, glands, arteries and immune cells undergo anatomical and functional transformation to create the decidua, the specialized secretory endometrium of pregnancy. The maternal decidua and the invading fetal trophoblast constitute a dynamic junction that facilitates a complex immunological dialogue between the two. The decidual and peripheral immune systems together assume a pivotal role in regulating the critical balance between tolerance and defense against infection. Throughout pregnancy, this equilibrium is repeatedly subjected to microbial challenge. Acute viral infection in pregnancy is associated with a wide spectrum of adverse consequences for both mother and fetus. Vertical transmission from mother to fetus can cause developmental anomalies, growth restriction, preterm birth and stillbirth, while the mother is predisposed to heightened morbidity and maternal death. A rapid, effective response to invasive pathogens is therefore essential in order to avoid overwhelming maternal infection and consequent fetal compromise. This sentinel response is mediated by the innate immune system: a heritable, highly evolutionarily conserved system comprising physical barriers, antimicrobial peptides (AMP) and a variety of immune cells-principally neutrophils, macrophages, dendritic cells, and natural killer cells-which express pattern-receptors that detect invariant molecular signatures unique to pathogenic micro-organisms. Recognition of these signatures during acute infection triggers signaling cascades that enhance antimicrobial properties such as phagocytosis, secretion of pro-inflammatory cytokines and activation of the complement system. As well as coordinating the initial immune response, macrophages and dendritic cells present microbial antigens to lymphocytes, initiating and influencing the development of specific, long-lasting adaptive immunity. Despite extensive progress in unraveling the immunological adaptations of pregnancy, pregnant women remain particularly susceptible to certain acute viral infections and continue to experience mortality rates equivalent to those observed in pandemics several decades ago. Here, we focus specifically on the pregnancy-induced vulnerabilities in innate immunity that contribute to the disproportionately high maternal mortality observed in the following acute viral infections: Lassa fever, Ebola virus disease (EVD), dengue fever, hepatitis E, influenza, and novel coronavirus infections.

Citing Articles

. Honey Exerts Antiviral Effect Against Influenza A Virus Infection Through Mitochondrial Stress-Mediated Enhancement of Innate Immunity.

Kwon E, Kim B, Kim Y, Na S, Han S, Woo S Antioxidants (Basel). 2025; 14(1).

PMID: 39857405 PMC: 11761272. DOI: 10.3390/antiox14010071.


Oxidative Stress Induced by Antivirals: Implications for Adverse Outcomes During Pregnancy and in Newborns.

Costa B, Gouveia M, Vale N Antioxidants (Basel). 2025; 13(12.

PMID: 39765846 PMC: 11727424. DOI: 10.3390/antiox13121518.


Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice.

Flores Malavet V, Dhume K, Satchmei A, Arvelo A, Beaird A, Annamalai S J Clin Invest. 2025; 135(1).

PMID: 39744951 PMC: 11684801. DOI: 10.1172/JCI179230.


Impact of antiphospholipid syndrome on placenta and uterine NK cell function: insights from a mouse model.

Martirosyan A, Kriegova E, Savara J, Abroyan L, Ghonyan S, Slobodova Z Sci Rep. 2024; 14(1):31163.

PMID: 39732740 PMC: 11682064. DOI: 10.1038/s41598-024-82451-2.


T Cell Responses to SARS-CoV-2 in Vaccinated Pregnant Women: A Comparative Study of Pre-Pregnancy and During-Pregnancy Infections.

Shen C, Hu S, Hou C, Shen C, Cheng C Vaccines (Basel). 2024; 12(11).

PMID: 39591111 PMC: 11598868. DOI: 10.3390/vaccines12111208.


References
1.
Kayem N, Benson C, Aye C, Barker S, Tome M, Kennedy S . Lassa fever in pregnancy: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2020; 114(5):385-396. PMC: 7197258. DOI: 10.1093/trstmh/traa011. View

2.
Kraus T, Engel S, Sperling R, Kellerman L, Lo Y, Wallenstein S . Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol. 2011; 32(2):300-11. PMC: 7086597. DOI: 10.1007/s10875-011-9627-2. View

3.
Pudney J, He X, Masheeb Z, Kindelberger D, Kuohung W, Ingalls R . Differential expression of toll-like receptors in the human placenta across early gestation. Placenta. 2016; 46:1-10. PMC: 5119647. DOI: 10.1016/j.placenta.2016.07.005. View

4.
Parsons L, An Y, Qi L, White M, van der Woude R, Hartshorn K . Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D: -Glycan Subtypes in Host-Pathogen Interactions. J Virol. 2019; 94(5). PMC: 7022373. DOI: 10.1128/JVI.01951-19. View

5.
Yan N, Chen Z . Intrinsic antiviral immunity. Nat Immunol. 2012; 13(3):214-22. PMC: 3549670. DOI: 10.1038/ni.2229. View